Equites Radar

ALGN · Align Technology, Inc.

Medical Instruments & SuppliesUnited StatesAnalyst view: Buy

$154.51

-0.64% last session

End-of-day data · close of 2026-10-23

Neutral2 bullish · 2 bearish technical signals
Consensus: Buy (2.25 from 14 analysts)
To mean target: +23.1%

Market cap

$11B

Enterprise value

$10B

Trailing P/E

26.9

Forward P/E

12.5

Dividend yield

0.0%

Beta

1.67

Avg volume

1M

Employees

20K

Daily Change %

-0.64%

5 Days Change

5.57%

10 Days Change

8.34%

30 Days Change

4.95%

60 Days Change

-2.59%

Month to Day Change

6.99%

Year to Day Change

-0.41%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)2.25
Covering analysts14
Mean price target$190.21
Low price target$155.00
Upside to mean target+23.1%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)59.9
50-day MA$152.07
200-day MA$169.28
Price vs 50-day MA+1.6%
Price vs 200-day MA-8.7%
MACD histogram1.94
Volume vs 3-month avg1.0×
52w low $131.9152w high $197.51

Analyst sentiment over time — ALGN

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-10-22

Latest call per bank · past 12 months

UBS

Neutral

$189

+22.3% vs price
▲ raised from $186Maintains · 2026-07-23

Morgan Stanley

Equal-Weight

$188

+21.7% vs price
▲ raised from $169Maintains · 2026-04-24

Citigroup

Buy

$240

+55.3% vs price
▲ raised from $0.00Initiates · 2026-04-15

Barclays

Overweight

$200

+29.4% vs price
Upgrade · 2026-03-17

HSBC

Buy

$200

+29.4% vs price
▲ raised from $150Upgrade · 2026-02-09

Wells Fargo

Overweight

$200

+29.4% vs price
▲ raised from $181Maintains · 2026-02-05

Recent rating actions

DateFirmActionRatingPrice target
2026-10-22MizuhoMaintainsOutperform$220 → $200
2026-10-21Piper SandlerMaintainsOverweight$235 → $205
2026-10-15BairdDowngradeOutperform → Neutral$218 → $162
2026-10-14Leerink PartnersMaintainsOutperform$235 → $215
2026-10-09StifelMaintainsBuy$210 → $175
2026-10-05Evercore ISI GroupDowngradeOutperform → In-Line$220 → $155
2026-07-23UBSMaintainsNeutral$186 → $189
2026-07-09BMO CapitalInitiatesOutperform$0.00 → $209

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-10-23

  • neutral: RSI (14): RSI is 60 — neutral momentum, neither overbought nor oversold.
  • bullish: Price vs 50-day MA: Trading 1.6% above the 50-day MA ($152.07).
  • bearish: Price vs 200-day MA: Trading 8.7% below the 200-day MA ($169.28).
  • bearish: MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
  • bullish: MACD (12,26,9): MACD histogram is positive (+1.94) — short-term momentum is improving.
  • neutral: 52-week range: Price sits between the 52-week low ($131.91) and high ($197.51).

ALGN Price Chart

Loading chart for ALGN…

Fundamentals

Revenue (TTM)$4.0B
EBITDA$1.0B
Free cash flow$1.0B
Operating cash flow$1.0B
Book value / share$59.41
Net Debt / EBITDA-1.1
WACC15.0%
Revenue growth4.00%
Earnings growth-12.00%

About Align Technology, Inc.

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

More in Medical Instruments & Supplies

Screen ALGN against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.